Alex Azar, President Donald Trump’s nominee for HHS Secretary, was paid nearly $2 million in his final year as an executive at pharmaceutical giant Eli Lilly and built a portfolio worth as much as $20.6 million in his nearly 10-year tenure at the company.

Several changes to Medicare Advantage and Medicare Part D prescription drug plans have been included in a proposed rule by CMS in an effort to fight opioid abuse among seniors while taking another step towards reducing regulations.

Between Nov. 1 and Nov. 11, nearly 1.5 million people signed up for health insurance coverage on the Healthcare.gov exchange, an increase of almost 500,000 from the same period last year.

HONOLULU – With the need for donated organs far exceeding the number available for transplantation in the U.S., the American Medical Association (AMA) adopted policy during its Interim Meeting this week aimed at increasing organ donation rates—particularly among minority populations with historically low donation rates.  

While platforms such as Facebook, Twitter and Instagram give people the ability to connect with anyone in the world, the American Medical Association (AMA) has announced the adoption of new policies outlining the negative health effects of social media.

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

Republican leaders in the Senate announced Nov. 14 they will include a repeal of the Affordable Care Act’s individual mandate in their tax reform proposal. After failing numerous times to repeal and replace the ACA, GOP leaders are hoping to include the healthcare reform in the tax bill.

The U.S. Food and Drug Administration (FDA) announced a public health advisory about risks associated with kratom, an herbal supplement used to treat pain and reduce opioid withdrawal symptoms.